Abstrakt

Urological cancer: A systematic review.

Ana Konety*

In the past two years, there were over two million new cases and around million fatalities related to urologic cancer. Although castration for prostate cancer, surgery, chemotherapy, and radiotherapy remain the cornerstones for treating urologic neoplasms, their severe side effects, low patient compliance, and unsatisfactory survival rates make it imperative to develop novel approaches that allow for the early detection of these malignancies, as well as accurate diagnoses and more effective treatment approaches.